Back to feed
News
Near-term (1-2 years)
January 12, 2026

TetraScience Announces Collaboration with Thermo Fisher Scientific to Accelerate Scientific Data and AI Enablement Across the Laboratory

1 day agocision

Summary

The companies will work together to help pharmaceutical organizations improve efficiency and deliver better outcomes for patients. BOSTON, Jan. 12, 2026 /PRNewswire/ -- TetraScience, the Scientific Data and AI company, today announced a collaboration with Thermo Fisher Scientific Inc.,...

Impact Areas

cost
revenue
strategic

Sector Impact

In Healthcare & Life Sciences, this collaboration should reduce R&D costs, accelerate drug discovery, and enable more personalized medicine approaches. Improved data and AI capabilities in manufacturing may lead to better process optimization, quality control, and predictive maintenance of lab equipment for Thermo Fisher customers.

Analysis Perspective
Executive Perspective

For pharmaceutical organizations, this collaboration promises to streamline AI/ML model development by providing cleaner, more accessible data. It can reduce the time and cost associated with data wrangling and feature engineering, allowing scientists to focus on model building and validation, automating critical parts of the drug discovery workflow. Improved data integration can lead to better model performance and more accurate predictions, leading to faster insights and better patient outcomes.

Related Articles
News
1 day ago
Copper is quickly becoming one of the more important commodities in the global economy, and a favourite for investors the world over. It is used in nearly all modern systems that move electricity and data, and demand is increasingly being pulled by grid expansions and capital spending linked to artificial intelligence (AI) data centres. The [...]The post Koryx Copper: A Namibian Success Story appeared first on The Namibian.
Research
21 hours ago
USA, New Jersey: According to Verified Market Research analysis, the global Medical Payment Integrity Market size was valued at USD 0.98 Billion in 2023 and is projected to reach USD 1.81 Billion by 2031, growing at a CAGR of 8.22%